Kick-Nic! Youth Quit Vaping App
Vaping Cessation Among Youth: Evaluating the Kick-Nic! App
Yale University
306 participants
Jan 16, 2025
INTERVENTIONAL
Conditions
Summary
High school students who want to quit vaping will be randomized to receive the Kick-Nic! app or a control NCI website to determine the efficacy of the app for vaping cessation. Participants will be screened for eligibility, then go through an 8 week treatment period where they will be given access to use the Kick-Nic! app or referred to the NCI Quit Vaping website. This will be followed by 1, 2, 3, and 6 month follow up visits. Qualitative interviews with participants and school staff will also be conducted to obtain feedback on the app and best ways to implement/disseminate the app. Abstinence rates will be assessed biweekly during treatment including at end of treatment (EOT), and then at 1, 2, 3 and 6 month follow ups (FU). Biochemical verification (salivary cotinine \< 30 ng.ml) of self-reports of abstinence will be conducted at EOT and 6-month FU.
Eligibility
Inclusion Criteria4
- high school aged youth (13-19 years old),
- regular current (past month) e-cig users using nicotine-containing e-cigs at least 1 day/week.
- want to quit using e-cigarettes.
- have a smartphone with data/WIFI plan in order to access and utilize the KickNic! app
Exclusion Criteria1
- Those who have non-stable (\<2 months) use of anxiolytics, antidepressants, and other psychostimulants or have a history of psychosis or any significant current psychiatric/medical condition that would increase risk will be excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Kick-Nic! app has seven modules that cover core CBT strategies using skills, graphic illustrations, and interactive components to help adolescents quit using e-cigarettes.
The NCI webpage provides quitting tobacco resources for youth, including for e-cigarettes. The information provided is similar to the CBT skills modeled by the Kick-Nic! app.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06662305